TOKYO: Japan’s Fujifilm Holdings said on Tuesday it is buying a subsidiary of Biogen for around US$890 million to bolster its healthcare business.
It said it expects the acquisition of Biogen Denmark Manufacturing to be completed in August.
The Denmark unit has a facility equipped with six 15,000 litre bioreactors that can manufacture cell culture-derived biologics.
Biogen said it expects the site’s 800 staff to remain employed.
Through the acquisition, Fujifilm aims to achieve its 100 billion yen (US$897.91 million) revenue target in its contact development and manufacturing organisation (CDMO) business by 2021, two years ahead of its original goal.
Fujifilm last year said it would buy two biotechnology units from compatriot JXTG Holdings for about US$800 million.